Clinical Trials in Pennsylvania

Showing 3721-3740 of 11,304 trials

Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis

NCT02432807

This is a Phase 3 study to evaluate the safety and efficacy of a vancomycin hydrochloride ophthalmic ointment dosed 4 times daily for 7 days compared to placebo (vehicle) in patients with moderate to severed Gram-positive bacterial conjunctivitis.

Bacterial Conjunctivitis

Kurobe LLC303 participantsStarted May 2015

Paramount, California, United States • Petaluma, California, United States • Rancho Cordova, California, United States +13 more locations

Active Not RecruitingPhase 1/295 miles

Durvalumab and Tremelimumab for Pediatric Malignancies

NCT03837899

The purpose of the study is to determine the recommended dose of durvalumab and tremelimumab (immunotherapy drugs) in pediatric patients with advanced solid and hematological cancers and expand in a second phase to test the efficacy of these drugs once this dose is determined.

Pediatric CancerSolid Tumor PediatricHematological Malignancies

AstraZeneca50 participantsStarted Mar 2019

Baltimore, Maryland, United States • Boston, Massachusetts, United States • New Hyde Park, New York, United States +16 more locations

Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis

Durvalumab and Tremelimumab for Pediatric Malignancies

Find Trials by Condition in Pennsylvania

Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer

A Study to Evaluate the Safety of Long-term Ivacaftor Treatment in Participants With Cystic Fibrosis Who Are Less Than 24 Months of Age at Treatment Initiation and Have an Approved Ivacaftor-Responsive Mutation

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)

Investigation of Clot in Ischemic Stroke and Hematoma Evacuation

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus

Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19

Trial Comparing Peripheral I.V. Catheter Complication Rates of Two Different Catheter Dressings

Stress Management Training for Healthy Aging

A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma

A Study of LY3022855 In Participants With Breast or Prostate Cancer

A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy

A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms